Reduction of CX3CL1 expression in the hypothalamus of mice provide mild reduction in brain inflammation and glucose tolerance, but not adiposity measures and body mass, suggesting this chemokine has a specific role in controlling HFD-induced obesity-related glucose metabolism (164). Here, CX3CL1 is linked to obesity due to melanocortin 4 receptor deficiency.